Professor of Chemistry and Biochemistry at the University of Notre Dame
University of Notre Dame
Dr. Lieberman is interested in developing analytical methods for use in low-resource settings. Her group designs paper millifluidic devices to carry out operations that are normally done in a laboratory setting, and tests those devices in Kenya, Malawi, Bangladesh, and other developing countries. The work focuses on detection of falsified and substandard pharmaceuticals, and assessment of iodine nutrition interventions. We are currently developing a paper test card to assess the quality of injectable chemotherapy drugs. We would be interested in working with anyone with a field project who wants to answer analytical questions without access to analytical lab instrumentation.
- Substandard cisplatin found while screening the quality of anti-cancer drugs from Addis Ababa, Ethiopia. Madeline D. Smith Eberle, Ayenew Ashenef, Heran Gerba, Patrick Loehrer, and Marya Lieberman. Journal of Global Oncology, 2020, 6:407-413. doi: 10.1200/JGO.19.00365.
- Paper Analytical Device to Detect the Presence of Four Chemotherapy Drugs, Madeline Smith, Ayenew Ashenef, and Marya Lieberman, 2018, Journal of Global Oncology, 4:1-10, doe: https://doi.org/10.1200/JGO.18.00198